Kim HD, Sym SJ, Chon HJ, Kim M, et al. Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab. J Hepatol 2025 Sep 4:S0168-8278(25)02457-2. doi: 10.1016/j.jhep.2025.
PMID: 41038766